Quiflapon

DB20376ExperimentalSmall molecule

Quiflapon is a small molecule drug. The usage of the INN stem '-flapon' in the name indicates that Quiflapon is a 5-lipoxygenase-activating protein (FLAP) inhibitor. Quiflapon has a monoisotopic molecular...

Mechanism: Pharmacologically active on Polyunsaturated fatty acid 5-lipoxygenase and Arachidonate 5-lipoxygenase-activating protein
Curator reviewed
Formula / weight: C₃₄H₃₅ClN₂O₃S · 587.18 g/mol (avg)

Resolves to

Compound

UNII9295C885I4CAS136668-42-3ChEMBLCHEMBL16596

Structure

InChIKeyNZOONKHCNQFYCI-UHFFFAOYSA-NSMILESCC(C)(C)SC1=C(CC(C)(C)C(O)=O)N(CC2=CC=C(Cl)C=C2)C2=CC=C(OCC3=NC4=CC=CC=C4C=C3)C=C12

Targets

P09917ALOX5P20292ALOX5AP

What you can answer from here — as of August 31, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Quiflapon, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account